Browsing by Author "Igdem, Sefik"
Now showing items 1-9 of 9
-
Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer
Ercan, Tuelay; Igdem, Sefik; Alco, Guel; Zengin, Funda; Atilla, Selin; Dincer, Maktav; Okkan, Sait (SPRINGER, 2010)The aim of this study was to be able to implement the field-in-field intensity-modulated radiotherapy (FiF) technique in our daily practice for breast radiotherapy. To do this, we performed a dosimetric comparison. Treatment ... -
INSUFFICIENCY FRACTURES AFTER PELVIC RADIOTHERAPY IN PATIENTS WITH PROSTATE CANCER
Igdem, Sefik; Alco, Guel; Ercan, Tuelay; Barlan, Metin; Ganiyusufoglu, Kuersat; Unalan, Buelent; Okkan, Sait (ELSEVIER SCIENCE INC, 2010)Purpose: To assess the incidence, predisposing factors, and clinical characteristics of insufficiency fractures (IF) in patients with prostate cancer, who received pelvic radiotherapy as part of their definitive treatment. ... -
Nasopharyngeal cancer around the Mediterranean area: Role of newer radiation techniques
Turkan, Sedat; Igdem, Sefik (ELSEVIER SCIENCE INC, 2012)Primary radiotherapy has been the mainstay of treatment of patients with nondisseminated nasopharyngeal cancer (NPC). Novel techniques, such as intensity modulated and image guided radiotherapy has the capability to generate ... -
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using Ga-68-PSMA PET/CT TROD 09-004 Study
Onal, Cem; Ozyigit, Gokhan; Akgun, Zuleyha; Atalar, Banu; Igdem, Sefik; Oymak, Ezgi; Agaoglu, Fulya (Lippincott Williams & Wilkins, 2021)Purpose To evaluate the outcomes of metastasis-directed treatment (MDT) using stereotactic body radiotherapy (SBRT) for bone-only oligometastasis (OM) detected with gallium prostate-specific membrane antigen (Ga-68-PSMA) ... -
Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007
Bicakci, Beyhan Ceylaner; Mustafayev, Teuta Zoto; Cetinayak, Oguz; Igdem, Sefik; Birgi, Sumerya Duru; Meydan, Deniz; Akman, Fadime (Wiley, 2022)Background To assess and report clinical outcomes after carotid sparing intensity-modulated radiotherapy for early stage laryngeal cancer. Methods We retrospectively analyzed 201 patients with early stage glottic laryngeal ... -
Prostatic Duct Adenocarcinoma: Clinical Characteristics, Treatment Options, and Outcomes - a Rare Cancer Network Study
Igdem, Sefik; Spiegel, Daphna Y.; Efstathiou, Jason; Miller, Robert C.; Poortmans, Philip M. P.; Koca, Sedat; Zietman, Anthony (KARGER, 2010)Background: To evaluate the clinical characteristics, contemporary treatment options, and outcome of prostatic duct adenocarcinoma (PDA), we initiated a Rare Cancer Network (RCN) study. Materials and Methods: Six member ... -
Treatment of prostate cancer by hypofractionated radiotherapy
Igdem, Sefik (MARMARA UNIV, FAC MEDICINE, 2015)Technological advances in radiation therapy delivery have permitted the use of high dose per fraction radiotherapy for early stage prostate cancer. Level I evidence supporting the safety and efficasy of hypofractionated ... -
Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)
Hurmuz, Pervin; Onal, Cem; Ozyigit, Gokhan; Igdem, Sefik; Atalar, Banu; Sayan, Haluk; Akyol, Fadil (Springer Heidelberg, 2020)Purpose the aim of this study was to evaluate the outcomes of(68)Ga prostate-specific membrane antigen (Ga-68-PSMA) positron-emission tomography (PET)/CT-based metastasis-directed treatment (MDT) for oligometastatic prostate ... -
Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy
Ozyigit, Gokhan; Onal, Cem; Igdem, Sefik; Alicikus, Zumre Arican; Iribas, Ayca; Akin, Mustafa; Akyol, Fadil (Springer Heidelberg, 2019)Purpose To validate the clinical outcomes and prognostic factors in prostate cancer (PCa) patients with Gleason score (GS) 8-10 disease treated with external beam radiotherapy (EBRT)+ androgen deprivation therapy (ADT) in ...
